Daiichi Sankyo, Japan’s second-largest pharma outfit, has agreed to pay up to $650 million to get its hands on some hydrocodone combo medications, striking a deal with Charleston Laboratories with hopes of cashing in on the demand for pain pills.

…read more

Source: Daiichi Sankyo bets up to $650M on Charleston’s pain potential


0 No comments